IVIM Health vs LTTL: Ratings, Pricing, and Compounding Quality
Quick verdict: IVIM Health emphasizes third-party satisfaction and a proprietary GLP-1 ID protocol with a free-month offer, while LTTL emphasizes full-dose compounded GLP-1 prepared in U.S. licensed pharmacies with lab verification. This article compares IVIM Health vs LTTL on pricing, clinical claims and verification, medication compounding and quality checks, and program structure.
Price and promotional differences
IVIM Health promotes a Limited Offer: Free Month Membership using code GIFT75, and a no-obligation free consultation stated as a $75 value. IVIM’s materials list compounded semaglutide at $75/mo and tirzepatide at $133/mo with a $74.99/mo program fee in some captured landing-page text, while an FAQ captured states IVIM starts at $99 for the first month and $174/month ongoing. LTTL’s captured content emphasizes a promotional credit of up to $140 off your first month with code auto-applied and shows pricing references such as $249 and $129 for different dose counts. Pricing details for both providers are presented with qualifiers and subject to the provider’s live offer or state availability.
Third-party ratings and trust signals
IVIM Health: captured evidence repeatedly notes a 4.9-star rating on both Google and Trustpilot and positions this dual rating as a rare third-party validation in the market. LTTL: the captured landing-page evidence did not include verified third-party ratings on the affiliate-captured page. These differences matter if external ratings influence your choice.
Medication type, compounding and regulatory notes
Both providers offer compounded GLP-1 medications in the captured materials and include the regulatory note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. IVIM’s copy also describes compounded semaglutide and tirzepatide offerings and reminds readers that compounded drugs have not undergone FDA review. LTTL’s captured text likewise states treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA-approved.
Pharmacy verification and quality control
LTTL highlights that medications are compounded by U.S.A. licensed pharmacies, independently verified in FDA registered labs, delivered to your door, and confirmed every 3–6 months to stay within plus or minus 10 percent of target strength in the captured evidence. IVIM’s materials state medications are prepared by independent, licensed compounding pharmacies and include safety information and peer-reviewed retrospective observational studies supporting outcomes; IVIM also stresses clinician-guided titration with weekly dose adjustments described in captured text.
| Criterion | IVIM Health | LTTL |
|---|---|---|
| Promotional offer | Free Month Membership with code GIFT75; no-obligation $75 consult | Up to $140 off first month; code auto-applied |
| Third-party ratings | 4.9 stars on Google and Trustpilot (captured) | Not verified on captured affiliate landing page |
| Medication type | Compounded semaglutide and tirzepatide; proprietary GLP-1 ID protocol | Compounded full-dose GLP-1 prepared by U.S. licensed pharmacies |
| Quality verification | Medications prepared by independent compounding pharmacies; safety info and peer-reviewed retrospective studies cited | Independently verified in FDA registered labs; confirmed every 3 to 6 months within plus or minus 10 percent |
| Regulatory note | Compounded drugs are not FDA-approved and have not undergone FDA review | Compounded medications are not FDA-approved and are not reviewed by FDA |
View LTTL lab verification and pharmacy details
Program structure and clinical claims
IVIM promotes a proprietary GLP-1 ID clinician-guided titration and optimization protocol that the provider says can accelerate weight loss outcomes by up to 40 percent compared to a referenced standard GLP-1 protocol; materials make clear this is a proprietary claim and not an independent clinical trial. IVIM also cites two peer-reviewed retrospective observational studies in Obesity Pillars as part of its outcomes discussion. LTTL emphasizes clinician-reviewed online treatment and full-dose GLP-1 formulations but the captured evidence notes that pricing, eligibility, pharmacy, state coverage and renewal terms may change and that some current details were not published or could not be verified on the captured affiliate landing page.
Safety and availability reminders
Both providers’ captured materials include the explicit regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Availability may be limited by state and treatment is subject to clinician review for medical appropriateness where stated.
IVIM Health vs LTTL: final take and who should pick which
In short, IVIM Health emphasizes dual 4.9-star third-party ratings, a proprietary GLP-1 ID protocol, and a free-month membership code; LTTL emphasizes U.S. licensed compounding pharmacies, FDA-registered lab verification and a promotional credit applied to the first month.
Choose IVIM Health if you want stronger captured third-party satisfaction signals, a clinician-guided GLP-1 ID protocol, and a free-month offer with a no-obligation $75 consultation.
Choose LTTL if you prioritize explicit captured statements about U.S. licensed compounding pharmacies, independent verification in FDA registered labs, and dosing confirmation every 3 to 6 months within the captured evidence.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
